| 注册
首页|期刊导航|中国临床药理学杂志|线粒体融合蛋白2在心血管疾病方面的研究现状

线粒体融合蛋白2在心血管疾病方面的研究现状

陶婷 张荣

中国临床药理学杂志2017,Vol.33Issue(7):668-672,5.
中国临床药理学杂志2017,Vol.33Issue(7):668-672,5.DOI:10.13699/j.cnki.1001-6821.2017.07.029

线粒体融合蛋白2在心血管疾病方面的研究现状

Research situation of mitochondrial fusion protein 2 and cardiovascular disease

陶婷 1张荣1

作者信息

  • 1. 哈尔滨医科大学 药学院 药理学教研室,哈尔滨150086
  • 折叠

摘要

Abstract

Mitochondrial fusion protein 2 (Mitofusin 2,Mfn2) is a kind of binding protein involved in multiple functions and responsible for the regulation of mitochondrial morphology and function,which is distributed in the outer mitochondrial membrane,mitochondria and endoplasmic reticulum membrane.Meanwhile,as an important intracellular signaling molecule,Mfn2 participates in the process of myocardial cell metabolism,proliferation,apoptosis,as well as,is closely related to the occurrence and development mechanism of many cardiovascular disease,such as hypertension,ischemia/reperfusion,dilated cardiomyopathy.This article will make a brief summary of the research situation of Mfn2 in cardiovascular disease.

关键词

线粒体融合蛋白2/线粒体/心血管疾病

Key words

mitochondrial fusion protein 2/mitochondria/cardiovascular disease

分类

医药卫生

引用本文复制引用

陶婷,张荣..线粒体融合蛋白2在心血管疾病方面的研究现状[J].中国临床药理学杂志,2017,33(7):668-672,5.

基金项目

国家自然科学基金面上基金资助项目(81470523) (81470523)

博士后科研启动基金资助项目(LBH-Q11057) (LBH-Q11057)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文